FDA Investigator Andrew J Molesky
Andrew J Molesky has conducted inspections on 55 sites in 1 countries as of 15 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
15 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrew J Molesky:
Aaron J Adler,
Amy Kim,
Amy L Singer,
Andrew F Cohen,
Anthony M Criscuolo, Jr,
Anthony R Rauert,
Ashley Polizzotto,
Ayorinde O Babalola,
Barbara J Maulfair,
Benjamin Bustamante,
Bernardica T Sculac Stern,
Christine M Rivera,
Coleburn E Vielehr,
Craig W Swanson,
David H Smith,
David R Delucia,
Devon Jenkins,
Dhaval H Patel,
Diane B Radice,
Emest F Bizjak,
Emilio Z Azukwu,
Eric Rothschild,
Frank A Boardwick,
Frank Verni,
Gianine E Tompkins,
Gobiga Vanniyasingam,
Jananiga Vanniyasingam,
Jason Kwong,
Jennifer L Custodio,
Jessica M Monteiro,
Joseph Duca,
Joy F Canlas,
Julianna M Chedid,
Justina A Vicioso,
Karen E D'orazio,
Katrina M D'egidio,
Kelly Doremus,
Kerry A Kurdilla,
Kerry D Noto,
Kim G Campbell,
Kimberley A Ricketts,
Kimberly A Coward,
Kristy L Bonner,
Laishan L Lam,
Laurie B Frazier,
Lawrence R Johnson,
Leticia S Jones,
Marjorie D Schultz,
Melba Trivera Clavell,
Melissa B Libby,
Meredith L Sheridan,
Milan S Mcgorty,
Mildred L Mccray,
Mohamad A Chahine,
Nicholas E Squillante,
Nicole Vaught,
Nikki S Ramirez,
Noreen Kurzam,
Onieka T Carpenter,
Pang Wong,
Pasquale L Leone,
Peter R Lenahan,
Phillip O Mathis,
Randolph Campos Santiago,
Raymond Liu,
Remache,
Robert C Howard,
Sandra Kershaw,
Sarah Forney,
Schultz,
Sean D Duke,
Selina M Mata,
Sharon Ferraro,
Sherri J Liu,
Susan M Halsted,
Tara K Carmody,
Tressa T Lewis,
Vaishali J Patel,
Valerie A Potopsingh,
Valerie C Reed,
William D Murray,
Willy A Orantes,
Wilmarie Marrero Santiago,
Yuyan Liang
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more